Bill Burns

Board Chair Bill Burns has held numerous leadership positions in the pharmaceutical industry throughout his career, including serving as CEO of the global Pharmaceutical Division of Roche. He has also served on the main boards of Roche, Genentech, Chugai, and as Lead non-executive director of Shire Pharmaceuticals and the smaller biotechnology companies Crucell, Biotie and Okairos. He is currently Chair of Molecular Partners and Vestergaard, and he is Vice Chair of Mesoblast. Additionally, Mr. Burns is a member of the Scientific Advisory Board of the Center for Integrated Oncology of the University of Cologne/Bonn and on the Board of Trustees to the Institute of Cancer Research in London. He previously served on the Wellcome Trust Board of Governors.